Literature DB >> 19270283

Evaluation of nitazoxanide and oxfendazole efficacy against cystic echinococcosis in naturally infected sheep.

Cesar M Gavidia1, Armando E Gonzalez, Luis Lopera, Cesar Jayashi, Roxana Angelats, Eduardo A Barron, Berenice Ninaquispe, Lucia Villarreal, Hector H Garcia, Manuela R Verastegui, Robert H Gilman.   

Abstract

Cystic echinococosis (CE) is a public health problem caused by Echinococcus granulosus. We aimed to determine the efficacy of nitazoxanide (NTZ) and oxfendazole (OXF) against CE in naturally infected sheep. A total of 151 ewes were assigned to the following groups: 15 mg/kg of NTZ weekly for five weeks (NTZ5); two rounds of 15 mg/ kg of NTZ a day for five days (NTZ5x2) two weeks apart; 30 mg/kg of OXF a week for 11 weeks (OXF11); 30 mg/kg of OXF plus 15 mg/kg of NTZ a week for 11 weeks (OXF/NTZ); and the control group. OXF11 and OXF/NTZ decreased the number of fertile cysts, increased the number of degenerated cysts, and were more efficacious (49.6-61.2%) against lung cysts and liver cysts (91.8-100%) than any other treatment group. OXF might be an additional strategy for control programs and an optional treatment of human CE after it is licensed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19270283      PMCID: PMC2673094     

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  37 in total

1.  Relationship between the efficacy of praziquantel treatment and the cystic differentiation in vivo of Echinococcus granulosus metacestode.

Authors:  M A Urrea-París; M J Moreno; N Casado; F Rodríguez-Caabeiro
Journal:  Parasitol Res       Date:  2002-01       Impact factor: 2.289

2.  Hydatid cyst of the liver-criteria for the selection of appropriate treatment.

Authors:  A Menezes da Silva
Journal:  Acta Trop       Date:  2003-02       Impact factor: 3.112

3.  Prevalence, intensity, and fertility of ovine cystic echinococcosis in the central Peruvian Andes.

Authors:  E L Dueger; R H Gilman
Journal:  Trans R Soc Trop Med Hyg       Date:  2001 Jul-Aug       Impact factor: 2.184

4.  Nitazoxanide compared with quinfamide and mebendazole in the treatment of helminthic infections and intestinal protozoa in children.

Authors:  Cesar E Davila-Gutierrez; Clemente Vasquez; Benjamin Trujillo-Hernandez; Miguel Huerta
Journal:  Am J Trop Med Hyg       Date:  2002-03       Impact factor: 2.345

Review 5.  Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern.

Authors:  Johannes Eckert; Peter Deplazes
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

6.  In vitro effects of nitazoxanide on Echinococcus granulosus protoscoleces and metacestodes.

Authors:  Mirjam Walker; Jean François Rossignol; Paul Torgerson; Andrew Hemphill
Journal:  J Antimicrob Chemother       Date:  2004-07-28       Impact factor: 5.790

7.  In vitro parasiticidal effect of Nitazoxanide against Echinococcus multilocularis metacestodes.

Authors:  Marianne Stettler; Renate Fink; Mirjam Walker; Bruno Gottstein; Timothy G Geary; Jean François Rossignol; Andrew Hemphill
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

Review 8.  Echinococcus granulosus infection: clinical presentation, medical treatment and outcome.

Authors:  Peter Kern
Journal:  Langenbecks Arch Surg       Date:  2003-11-05       Impact factor: 3.445

Review 9.  Concepts in immunology and diagnosis of hydatid disease.

Authors:  Wenbao Zhang; Jun Li; Donald P McManus
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

10.  Human echinococcosis (hydatidosis) in Uruguay: a comparison of indices of morbidity and mortality, 1962-71.

Authors:  P Purriel; P M Schantz; H Beovide; G Mendoza
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

View more
  8 in total

Review 1.  Oxfendazole: a promising agent for the treatment and control of helminth infections in humans.

Authors:  Armando E Gonzalez; Ellen E Codd; John Horton; Hector H Garcia; Robert H Gilman
Journal:  Expert Rev Anti Infect Ther       Date:  2018-12-10       Impact factor: 5.091

Review 2.  Pulmonary cystic echinococcosis.

Authors:  Saul Santivanez; Hector H Garcia
Journal:  Curr Opin Pulm Med       Date:  2010-05       Impact factor: 3.155

3.  Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: Compounds and therapeutic targets.

Authors:  Mar Siles-Lucas; Adriano Casulli; Roberto Cirilli; David Carmena
Journal:  PLoS Negl Trop Dis       Date:  2018-04-20

Review 4.  Evaluation of nitazoxanide for the treatment of disseminated cystic echinococcosis: report of five cases and literature review.

Authors:  José A Pérez-Molina; Marta Díaz-Menéndez; José I Gallego; Francesca Norman; Begoña Monge-Maillo; Ana Pérez Ayala; Rogelio López-Vélez
Journal:  Am J Trop Med Hyg       Date:  2011-02       Impact factor: 2.345

5.  In vivo and in vitro efficacies of mebendazole, mefloquine and nitazoxanide against cyst echinococcosis.

Authors:  Congshan Liu; Haobing Zhang; Jianhai Yin; Wei Hu
Journal:  Parasitol Res       Date:  2015-03-15       Impact factor: 2.289

6.  Shortage of Albendazole and Its Consequences for Patients with Cystic Echinococcosis Treated at a Referral Center in Italy.

Authors:  Tommaso Manciulli; Ambra Vola; Mara Mariconti; Raffaella Lissandrin; Marcello Maestri; Christine M Budke; Francesca Tamarozzi; Enrico Brunetti
Journal:  Am J Trop Med Hyg       Date:  2018-10       Impact factor: 2.345

7.  Evaluation of oxfendazole, praziquantel and albendazole against cystic echinococcosis: a randomized clinical trial in naturally infected sheep.

Authors:  Cesar M Gavidia; Armando E Gonzalez; Eduardo A Barron; Berenice Ninaquispe; Monica Llamosas; Manuela R Verastegui; Colin Robinson; Robert H Gilman
Journal:  PLoS Negl Trop Dis       Date:  2010-02-23

8.  Nanostructured lipid carriers of ivermectin as a novel drug delivery system in hydatidosis.

Authors:  Ehsan Ahmadpour; Zahra Godrati-Azar; Adel Spotin; Roghayeh Norouzi; Hamed Hamishehkar; Sanam Nami; Peyman Heydarian; Saba Rajabi; Maryam Mohammadi; Gregorio Perez-Cordon
Journal:  Parasit Vectors       Date:  2019-10-10       Impact factor: 3.876

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.